The safety profile of biologic agents in comparison with non‐biologic systemic agents, and topical compounds in the management of psoriasis—A 30‐month prospective, observational cohort study-Reference-Cited by-同舟云学术

The safety profile of biologic agents in comparison with non‐biologic systemic agents, and topical compounds in the management of psoriasis—A 30‐month prospective, observational cohort study

Published:2021-10-05 Issue:12 Volume:75 Page:
ISSN:1368-5031
Container-title:International Journal of Clinical Practice
language:en
Short-container-title:Int J Clinical Practice

Author:

Marques Emanuel¹²,Paluch Zoltán²³,Boháč Petr⁴,Slanař Ondřej⁵,Běláček Jaromír⁶,Hercogová Jana⁴⁷

Affiliation:

1. Department of Dermatovenereology Third Faculty of Medicine Charles University and Králosvské Vinohrady University Hospital Prague Czech Republic

2. Department of Pharmacology Second Faculty of Medicine Charles University Prague Czech Republic

3. St. John Nepomucene Neumann Institute, Příbram, Czech Republic St. Elisabeth University of Health Care and Social Work Bratislava Slovak Republic

4. Department of Dermatovenerology Second Faculty of Medicine, Charles University and Bulovka University Hospital Prague Czech Republic

5. Department of Pharmacology First Faculty of Medicine Charles University Prague Czech Republic

6. Department of Statistics and Operation Analysis Faculty of Business and Economics of Brno Mendel University in Brno Brno Czech Republic

7. Department of Dermatovenerology Second Faculty of Medicine Charles University Prague Czech Republic

Publisher

Hindawi Limited

Subject

General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/ijcp.14915

Reference58 articles.

1. Epidemiology of Psoriasis

2. Psoriasis and its management

3. Global Epidemiology of Psoriasis: A Systematic Review of Incidence and Prevalence

4. The economic impact of psoriasis increases with psoriasis severity

5. Psoriasis and body mass index

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Secukinumab for the Treatment of Psoriasis in Pediatrics: Patient Selection and Acceptability;Patient Preference and Adherence;2023-02

2. Adalimumab/infliximab;Reactions Weekly;2022-09-24

3. Patient Preference for Biologic Treatments of Psoriasis in the Chinese Setting;Patient Preference and Adherence;2022-04